DIFFERENCES IN BLOOD GLUTATHIONE LEVELS OF PATIENTS WITH ADVANCED OR LOCALIZED CARCINOMA

Authors
Citation
A. Engin, DIFFERENCES IN BLOOD GLUTATHIONE LEVELS OF PATIENTS WITH ADVANCED OR LOCALIZED CARCINOMA, Tumori, 81(2), 1995, pp. 132-134
Citations number
18
Categorie Soggetti
Oncology
Journal title
TumoriACNP
ISSN journal
03008916
Volume
81
Issue
2
Year of publication
1995
Pages
132 - 134
Database
ISI
SICI code
0300-8916(1995)81:2<132:DIBGLO>2.0.ZU;2-0
Abstract
Aims and background: The increased level of blood glutathione (GSH) is an important biochemical feature in animal epithelial tumor. The aim of this study was to investigate the blood GSH concentrations in well characterized cancer patients and healthy volunteers. Methods: Two dif ferent groups of carcinoma cases were used. The first group consisted of 15 blood samples drawn from disseminated gastric adenocarcinoma pat ients, and the second group comprised 15 samples obtained from localiz ed or locally advanced skin carcinoma cases without lymph node metasta sis. GSH and hemoglobin concentrations were measured by using the meth od of Beutler et al. Results: The mean blood GSH in patients who had a dvanced malignant disease was 129.73 +/- 7.49 mg/dl and in patients wh o had localized cancer was 96.24 +/- 3.90 mg/dl. These results indicat e that the blood GSH level is 31% higher in localized carcinoma cases and 78% higher in metastatic disease than those of controls. Blood GSH concentrations were expressed on the basis of blood volume and also o n hemoglobin content. Similar results were calculated with either mode of expression. Conclusion: By comparing the two groups of patients, w e found that higher blood GSH concentration was correlated with metast atic growth.